ADM Tronics Issues Shareholder Update Letter

NORTHVALE, NJ / ACCESSWIRE / June 5, 2023 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, today issued an update letter from President and CEO, Andre' DiMino, to the Company's shareholders and other interested parties. The letter in its entirety follows:

June 5, 2023

Dear ADM Tronics Shareholder,

I want to thank you, and every one of our shareholders, for your loyalty and your belief in ADM Tronics. Your investment has allowed us to be laser-focused on building a robust pipeline of products and has allowed us to develop what we believe to be our game-changing Sonotron^® technology to treat pain. We are planning to commercially launch the Vet-Sonotron^® - for pets and animals - and later, The Sonotron^® for human medical applications. We have a major financial and time investment in the development of this technology that we believe will reward ADMT with significant revenues and profits.

We are especially proud that our Sonotron technology has demonstrated a giant leap in treating pain without the use of drugs or opioids. I invite you to watch this short video demonstrating the Vet-Sonotron's pain relief and visible inflammation reduction for a racehorse that was suffering an acute painful injury during a race.

The demand for solutions to treat pain for both animals and humans is very large. American pet owners will spend about $2 billion in 2023 for pain management for their pets. The National Academy of Sciences estimated in 2010 that more than 100 million American individuals experienced chronic unrelieved pain. The estimated cost was $560 billion to $635 billion per year, composed of direct health care costs of between $261 billion to $300 billion.

Our Sonotron device demonstrates unprecedented pain relief that is non-invasive and has no known adverse side effects. Over the decades, I have witnessed many different devices for treating pain, including drugs and opioids, but have never seen anything that works this well, this fast, with long-lasting results, and with no known adverse side effects. This is truly an exceptionally effective pain treating device that we believe has the potential to become a widespread solution for treating pain without drugs for both animals and for humans.